| Literature DB >> 34209100 |
Martina Felici1, Benedetta Tugnoli2, Andrea Piva1,2, Ester Grilli1,3.
Abstract
Avian coccidiosis is a disease causing considerable economic losses in the poultry industry. It is caused by Eimeria spp., protozoan parasites characterized by an exogenous-endogenous lifecycle. In vitro research on these pathogens is very complicated and lacks standardization. This review provides a description of the main in vitro protocols so far assessed focusing on the exogenous phase, with oocyst viability and sporulation assays, and on the endogenous phase, with invasion and developmental assays in cell cultures and in ovo. An overview of these in vitro applications to screen both old and new remedies and to understand the relative mode of action is also discussed.Entities:
Keywords: Eimeria; botanicals; cell culture; essential oils; in vitro; invasion assay; poultry
Year: 2021 PMID: 34209100 PMCID: PMC8300270 DOI: 10.3390/ani11071962
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Schematic representation of coccidian life cycle. Numbers indicate the developmental stages of Eimeria spp. and the host structures involved: (1) unsporulated oocysts; (2) sporulated oocysts; (3) gastrointestinal tract; (4) mechanical rupture of oocysts and sporocyst release; (5) excystation of sporozoites; (6) released sporozoites; (7) enterocytes; (8) trophozoite; (9) mature schizont; (10) merozoites and re-infection of enterocytes; (11) macrogamete; (12) microgamete; (13) zygote.
Main Eimeria spp. infecting chickens with their relative site of infection and level of lesion severity (adapted from [4]).
| Species | Site | Pathogenicity |
|---|---|---|
|
| Upper small intestine | Medium |
|
| Distal small intestine and colon | High |
|
| Mid small intestine | Medium |
|
| Upper small intestine | Low |
|
| Mid small intestine | High |
|
| Ceca | High |
Cell cultures used in Eimeria in vitro research.
| Cell Type | Stage of Development | Reference | |
|---|---|---|---|
| Bovine kidney cells |
| Merozoites | [ |
| cEF |
| Schizonts | [ |
| HeLa, Human Amnion, PCK, cEF, mouse fiboblasts |
| Trophozoites | [ |
| PCK cells |
| Oocysts | [ |
| PCK cells |
| Merozoites | [ |
| PCK cells |
| Merozoites | [ |
| PCK cells |
| Schizonts | [ |
| Caco-2, LMH, BHK, MDBK, HCT-8, VERO, MDCK, RK-13, IEC-6 |
| Merozoites | [ |
| cIECs |
| Merozoites | [ |
| CLEC-213 | Transgenic | Gametes | [ |
Figure 2Schematic representation of an embryonated egg model. The syringe shows the site of inoculation preferred for Eimeria research.
Main indicators to assess the severity of Eimeria infections in ovo.
| Method | Pathogen | Method Description | Reference |
|---|---|---|---|
| Embryo mortality |
| Percentage of dead embryos 3 days post inoculation was considered as caused by | [ |
| Oocyst production |
| Oocyst count in the allantoic cavities at day 7 post-infection | [ |
| Schizont dimension | Absence of large second generation schizonts in the CAM is linked to loss in pathogenicity | [ | |
| CAM foci count |
| Count of foci corresponding to second generation schizonts on the CAM | [ |
| Lesion scoring | 0 = no lesion | [ | |
| Histological observation | Yellow inflammatory foci containing necrotic material and leukocytic infiltration on the CAM | [ | |
| qPCR |
| Absolute DNA quantification by a plasmid containing ITS1 region insert. The | [ |
Main anticoccidial drugs and relative mode of action and target.
| Anticoccidial Drug | Mode of Action | Target Stage of | Lowest Effective Concentration In Vitro | In Vitro Test | Reference | |
|---|---|---|---|---|---|---|
| Amprolium | Inhibition of thiamine uptake | Second generation schizonts |
| 4 µg/mL | Development assay | [ |
| Clopidol | Inhibition of mitochondrial respiration | Sporozoites and sporulation |
| 4 µg/mL | Development assay | [ |
| Decoquinate | Inhibition of mitochondrial respiration | Sporozoites and sporulation |
| 0.01 µg/mL | Development assay | [ |
| Diclazuril | Nucleoside analogue | Late stages of development |
| 0.125 µg/mL | Sporulation assay | [ |
| Lasalocid | Ionophore | Sporozoite and trophozoite | Various spp. | 0.5 µg/mL | Invasion and development assay | [ |
| Monensin | Ionophore | Sporozoite and trophozoite | Various spp. | 0.001 µg/mL | Development assay | [ |
| Narasin | Ionophore | Sporozoite and trophozoite | Various spp. | 0.01 µg/mL | Electron microscopy | [ |
| 1 µg/mL | Invasion and development assay | [ | ||||
| Nicarbazin | Inhibition of succinate dehydrogenase and accumulation of intracellular calcium | Schizonts | Various spp. | 4 µg/mL | Development assay | [ |
| Robenidine | Guanidine derivate | Schizonts | Various spp. | 4 µg/mL | Development assay | [ |
| Salinomycin | Ionophore | Sporozoite and trophozoite | Various spp. | 0.1 µg/mL | Invasion and development assay | [ |
| Toltrazuril | Inhibition of mitochondrial respiration | Sporozoites, schizonts and gametes | Various spp. | 5 µg/mL | Invasion and development assay | [ |
Botanicals whose action on the exogenous phase has been assessed by in vitro methods (essential oil, EO).
| Compound | Concentration | Method | Reference | |
|---|---|---|---|---|
| Allium sativum | 10 g/L | Sporulation rate | [ | |
| Artemisia EO | 4 g/L | 273 nm absorbance | [ | |
| Artemisia absinthium EO | 50 g/L |
| Sporulation rate | [ |
| Artemisinin | 0.01–0.017 g/L |
| Sporulation rate | [ |
| Boesenbergia pandurate EO | 0.125 g/L |
| Sporulation rate | [ |
| EOBiarum bovei EO | 50 g/L |
| Sporulation rate | [ |
| Clove EO | 4 g/L | 273 nm absorbance | [ | |
| Curcumin | 10 g/L | Sporulation rate | [ | |
| Dorema aucheri EO | 50 g/L |
| Sporulation rate | [ |
| Nectaroscorum tripedale EO | 50 g/L |
| Sporulation rate | [ |
| Ocimum basilicum EO | 0.125 g/L |
| Sporulation rate | [ |
| Olive pulp | 0.023–0.371 g/L | 273 nm absorbance | [ | |
| Prangos ferulacea, EO | 50 g/L |
| Sporulation rate | [ |
| Pinus radiata extract | 0.250–1 g/L | Sporulation rate | [ | |
| Thyme EO | 4 g/L | 273 nm absorbance | [ | |
| Tea tree EO | 4 g/L | 273 nm absorbance | [ | |
| Green tea extract (Camellia sinensin) | 100 g/L | Sporulation rate | [ |
Botanicals whose action on the endogenous phase has been assessed by in vitro invasion assays (essential oil, EO; Madin Darby Bovine Kidney, MDBK).
| Compound | Concentration | Method | Reference | |
|---|---|---|---|---|
| Allicin | 1.8 × 10−3–1.8 × 103 µg/mL |
| Infection on MDBK and qPCR detection | [ |
| Betaine | 0.5 µg/mL |
| Infection on MDBK and count in HE stain | [ |
| Carvacrol | 20 µg/mL |
| Infection on MDBK and count in HE stain | [ |
| Curcumin | 73.6 µg/mL |
| Infection on MDBK and flow cytometry quantification | [ |
| Curcumin | 0.2 µg/mL |
| Infection on MDBK and count in HE stain | [ |
| Echinacea purpurea extract | 2 µg/mL |
| Infection on MDBK and count in HE stain | [ |
| Garlic EO | 50 µg/mL |
| Infection on MDBK and qPCR detection | [ |
| Oregano EO | 100 µg/mL |
| Infection on MDBK and qPCR detection | [ |
| Saponins | 10 µg/mL | Infection on MDBK and extracellular counts and qPCR | [ | |
| Thymol and carvacrol | 14 µg/mL | Infection on MDBK and extracellular counts and qPCR | [ | |
| Thonningia sanguinea extract | 625–40,000 µg/mL | Infection on MDBK and counts Giemsa stain | [ |